The established healthcare sector in North America is one of the primary elements fueling the region's epistaxis industry and making it one of the most profitable areas in the global market. Furthermore, increased consumer awareness of various strategies for treating nose bleeding concerns such as epistaxis is likely to drive regional market expansion.
The global Epistaxis Market size is estimated to be valued at US$ 145.9 million in 2019 and is expected to witness a CAGR of 5.4% over the forecast period (2019–2027). As a result of recent developments in medical research and the development of new medications and therapies to successfully address a number of health-related concerns, the United States is anticipated to experience an increase in demand for newer products for the management of epistaxis. Furthermore, changes in American consumers' lifestyles, such as an increase in smoking prevalence and an increase in air pollution, are likely to increase the risk of epistaxis.
The increasing incidence of allergies is also driving the demand for Epistaxis Market. Allergic rhinitis, also known as hay fever, is a common condition that affects up to 30% of the population worldwide. It is characterized by inflammation of the nasal cavity, which can lead to nosebleeds in some cases. The prevalence of allergies is expected to increase in the coming years due to factors such as pollution, climate change, and changes in lifestyle. This trend is likely to drive the demand for Epistaxis treatment, particularly for those who experience nosebleeds as a result of their allergies.
Read More- https://cmi-latestreportorientedblogs.blogspot.com/2023/04/global-epistaxis-market-is-expanding.html
